ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis

Breast Cancer trials near Budapest, Budapest, HUN:

Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)

-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this study, anti-h...

Enrolling
Breast Cancer Recurrent
Drug: Standard endocrine therapy
Drug: Palbociclib 125mg

Phase 3

ETOP IBCSG Partners Foundation

Budapest, Hungary and 52 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Enrolling
Breast Cancer
Locally Advanced Breast Cancer
Drug: Samuraciclib
Drug: Fulvestrant

Phase 2

Carrick Therapeutics

Budapest, Hungary and 30 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Budapest, Hungary and 324 other locations

Recently updated

To compare and evaluate the efficacy and safety of Liporaxel® solution (oral paclitaxel) and Taxol® (IV paclitaxel) on recurrent or metastatic breast...

Active, not recruiting
Recurrent or Metastatic Breast Cancer
Drug: Oral paclitaxel
Drug: Paclitaxel injection

Phase 2, Phase 3

Daehwa Pharmaceutical

Tatabánya, Hungary and 50 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Vinorelbine
Drug: Eribulin

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 166 other locations

mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatmen...

Active, not recruiting
Breast Cancer
Drug: Fulvestrant

Phase 3

AstraZeneca
AstraZeneca

Székesfehérvár, Hungary and 102 other locations

PAKT was an investigator-led, placebo-controlled, randomized phase II trial performed in 42 academic medical centers in the United Kindom, South Kore...

Active, not recruiting
Metastatic Breast Cancer
Drug: AZD5363
Drug: Paclitaxel

Phase 2

Queen Mary University of London

Budapest, Hungary and 45 other locations

PREcoopERA is a randomized (2:2:1), multicenter, open-label, three-arm (A, B, C), Window-of-Opportunity (WOO) trial to evaluate the activity and safe...

Enrolling
Breast Cancer
Drug: Triptorelin
Drug: Anastrozole

Phase 2

ETOP IBCSG Partners Foundation

Budapest, Hungary and 43 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Trastuzumab deruxtecan
Drug: Capecitabine

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 293 other locations

with hormone receptor-positive (HR-positive), HER2-negative advanced breast cancer (aBC) who have not received prior therapy for ad...

Active, not recruiting
Breast Cancer
Drug: Letrozole
Drug: Anastrozole

Phase 2

Novartis
Novartis

Budapest, Hungary and 89 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems